DURECT CORP.      DL-,001
DURECT CORP. DL-,001
Share · US2666055007 · DRRX · A3DZZ2 (XNCM)
Overview Financial Indicators
0,49 EUR
3,70 % 0,02 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 19:48

Current Prices from DURECT CORP. DL-,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DRRX
USD
10.06.2025 19:48
0,56 USD
0,54 USD
+3,70 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,68 % -24,74 % -33,58 % -34,58 % -62,68 % -97,62 %

Company Profile for DURECT CORP. DL-,001 Share

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Company Data

Name DURECT CORP. DL-,001
Company DURECT Corporation
Symbol DRRX
Website https://www.durect.com
Primary Exchange XNCM Frankfurt
WKN A3DZZ2
ISIN US2666055007
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. James E. Brown D.V.M.
Market Capitalization 23 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 10260 Bubb Road, 95014-4166 Cupertino
IPO Date 2000-09-28

Ticker Symbols

Name Symbol
Frankfurt DC8A.F
NASDAQ DRRX

More Shares

Investors who DURECT CORP. DL-,001 hold also have the following shares in their portfolio:
BPCE SFH  11/21 MTN
BPCE SFH 11/21 MTN Bond
NEURAL THERAPEUT. INC.
NEURAL THERAPEUT. INC. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025